ARCHIVES

In this 12-page issue: Moonlighting by NCI and FDA scientists conflicted with CRADA work, House Subcommittee on Oversight and Investigations says.

This article is from The Cancer Letter archive.

Vol. 30 No. 21 | May 21, 2004

Download PDF Visit The Full Archive

Related Articles

NCAB Seeks Exemption From New Reimbursement Plan For Clinical Trials, Modification Of Hospice Regs

February 11, 1983

Cancer Act Pulled Entire NIH Budget Up, Schmidt Says

July 20, 1984

Broder Sworn In, Cites Three ‘Teachers’ – Gallo, Waldermann, DeVita

January 27, 1989

Decisively Positive Swedish Study of PSA Becomes Focus of Debate Over Screening

October 28, 2011

In Brief: O’Conor Names NCI Liaison To IARC, Saunders Acting IA Director Susan Sieber DCCP Deputy

May 27, 1983

Groups Push for CMS Coverage for LDCT Lung Screening

October 3, 2014